Denali Therapeutics DNLI
NASDAQ DNLI
$18.68 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Amortization of Deferred Charges (2024 - 2026)

Updated

Analysis

Denali Therapeutics (DNLI) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Denali Therapeutics 3.41 Bn -4.18 Mn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 915,000.00
Mar 31, 2026 916,000.00
Dec 31, 2025 916,000.00
Sep 30, 2025 900,000.00
Jun 30, 2025 911,000.00
Mar 31, 2025 887,000.00
Dec 31, 2024 766,000.00
Sep 30, 2024 400,000.00
API Access

Denali Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=DNLI&period=max&api_key=YOUR_API_KEY